Zepp Health reported Q2 2026 revenue of $63.5M, up 6.9% year-over-year, driven by new product launches and improved product mix. Gross margin improved to 37.4%, but net loss widened to $11.3M due to foreign exchange headwinds and increased spending on R&D and marketing. The company launched new wearable products and plans to raise prices on its Bip family in 2027 to improve unit economics. For Q3 2026, Zepp expects revenue between $68M and $73M, reflecting ongoing supply recovery and product ramp-up.
MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...
On September 22, 2026, Ethereum (ETH) traded around $2,735, just below a key resistance zone between $2,750 and $2,800 where it has repeatedly bounced. Despite a recent upward trend, ETH failed to sustain above $2,800, signaling uncertainty in short-...
FirstService Residential has published its 2026 BENCHMARK report detailing operating costs, budgets, and trends in large master-planned and lifestyle communities across North America. The report highlights key budget areas like insurance, utilities, ...
The ALPS Medical Breakthroughs ETF (SBIO) focuses on late-stage biotech companies that have at least one Phase II or III clinical program and sufficient cash reserves to reduce dilution risk before key events. This strategy aims to capture upside fro...
McDonald’s is piloting a program to sell advertising space on its digital menu boards, displayed after customers place orders in drive-thrus and restaurants. The company aims to offer relevant content without disrupting the McDonald’s experience. Thi...
